511541-63-2

Usage

Uses

Used in Pharmaceutical Research:
2-Amino-3-bromo-6-methoxypyridine is used as a building block for the development of new drugs due to its unique chemical structure and potential biological activities. It serves as a key intermediate in the synthesis of pharmaceutical compounds, contributing to the discovery and creation of novel therapeutic agents.
Used in Agrochemical Development:
In the agrochemical industry, 2-Amino-3-bromo-6-methoxypyridine is utilized as a precursor in the synthesis of new agrochemicals. Its properties make it suitable for the development of compounds with potential applications in crop protection and pest control.
Used in Organic Synthesis:
2-Amino-3-bromo-6-methoxypyridine is used as a reagent in chemical reactions for the preparation of heterocyclic compounds. Its presence in these reactions facilitates the formation of complex organic molecules, which are essential in various chemical and pharmaceutical applications.
Used in Biological Research:
Due to its range of biological activities, 2-Amino-3-bromo-6-methoxypyridine is employed in biological research to study its effects on various biological systems. This research can lead to a better understanding of its potential applications in medicine and other fields.

Upstream product

• 511541-62-1 6-amino-5-bromopyridin-2-ol 
• 77-78-1 dimethyl sulfate 
• 74-88-4 methyl iodide 
• 5154-00-7 6-amino-pyridin-2-ol 

Downstream Products

• 511541-68-7 6-Methoxy-3-(3-methoxy-phenyl)-pyridin-2-yl-amine 
• 511541-66-5 3-(4-fluoro-phenyl)-6-methoxy-pyridin-2-yl-amine 
• 511541-64-3 6-methoxy-3-phenyl-pyridin-2-yl-amine 
• 511541-67-6 3-(4-chloro-phenyl)-6-methoxy-pyridin-2-yl-amine 
• 511541-65-4 3-(3-Fluoro-phenyl)-6-methoxy-pyridin-2-yl-amine 
• 1005475-54-6 1,2-diamino-3-bromo-6-methoxy-pyridinium 2,4,6-trimethyl-benzenesulfonate 

Relevant academic research and scientific papers

RIP1K INHIBITORS

Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceut

TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES

The present invention relates to a compound according to formula I, wherein R1, R2 and A are as defined herein, which exhibit PDE4 inhibitory activity and may be used in the treatment of inflammatory diseases or autoimmune diseases,

DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS

Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.

Adenosine receptor ligands

The present application relates to compounds of the formula wherein R1 is hydrogen, halogen or lower alkoxy; R2 is hydrogen or is —C(O)-lower alkyl or —C(O)-phenyl, wherein the phenyl ring is unsubstituted or substituted by one or two substituents selected from the group consisting of halogen, lower alkyl, lower alkoxy and trifluoromethyl, or is —C(O)-furanyl or —C(O)-thiophenyl, wherein the rings are unsubstituted or substituted by halogen; or a pharmaceutically acceptable salt thereof. The compounds are useful in the treatment of diseases associated with the adenosine A2 receptor.